What are the clinical presentations of alcoholic hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Alcoholic hepatitis typically presents with a recent onset of jaundice, often accompanied by fever, malaise, weight loss, and malnutrition, in patients with a history of heavy alcohol use. The clinical presentation of alcoholic hepatitis can vary, but common symptoms include jaundice, right upper quadrant abdominal pain, hepatomegaly, and signs of liver decompensation such as ascites and encephalopathy 1. Laboratory findings often show elevated liver enzymes with AST typically higher than ALT (AST:ALT ratio >1.5), elevated bilirubin, prolonged prothrombin time, and leukocytosis 1.

Some key features of alcoholic hepatitis include:

  • Progressive jaundice
  • Fever with or without infection
  • Weight loss and malnutrition
  • Tender hepatomegaly
  • Ascites and encephalopathy in severe cases
  • Elevated AST and ALT with an AST:ALT ratio >1.5
  • Elevated bilirubin and prolonged prothrombin time

The diagnosis of alcoholic hepatitis is based on clinical and laboratory findings, and liver biopsy can be useful in confirming the diagnosis and assessing prognosis 1. However, the decision to perform a liver biopsy should be made on a case-by-case basis, taking into account the availability of the procedure and the experience of the team. The most recent and highest quality study recommends that liver biopsy be performed only in cases where there is diagnostic uncertainty 1.

In terms of prognosis, the severity of alcoholic hepatitis can range from mild to severe, with severe cases having a high mortality rate 1. Discriminator functions like Maddrey's Discriminant Function (DF) or the MELD score can help assess severity and guide treatment decisions. Early recognition of this condition is crucial as mortality increases significantly with disease severity. The current evidence suggests that treatment for severe alcoholic hepatitis may include corticosteroids or pentoxifylline, as well as nutritional support, alcohol abstinence, and management of complications 1.

From the Research

Clinical Presentation of Alcoholic Hepatitis

  • The clinical presentation of alcoholic hepatitis is characterized by fatigue, malaise, and jaundice in individuals who have abused excessive quantities of alcohol 2.
  • Common early presenting signs and symptoms of alcohol abuse include anorexia, weight loss, fatigue, symptoms of alcohol withdrawal, and hepatomegaly 3.
  • The clinical diagnosis of alcoholic hepatitis can be made in alcoholics with associated fever, leukocytosis, jaundice, and tender hepatomegaly 3.
  • Laboratory abnormalities may include leukocytosis or leukopenia, anemia, a prolonged prothrombin time, and elevated liver enzymes, including aspartate amino-transferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, and bilirubin 3.
  • An AST-to-ALT ratio greater than 2 is common in patients with alcoholic hepatitis 3.

Diagnosis and Prognosis

  • The diagnosis of alcoholic hepatitis is primarily clinical, based on a consensus definition from the National Institute on Alcohol Abuse and Alcoholism 4.
  • Laboratory-based prognostic scores, including Maddrey Discriminant Function and the Model for End-Stage Liver Disease, help determine disease severity and treatment options 4.
  • The Lille score at day 7 of treatment is used to evaluate responsiveness to corticosteroid therapy 4.
  • Baseline prothrombin time (BPT) can predict the response to steroid therapy in severe alcoholic hepatitis, with higher BPT values associated with a lower likelihood of response 5.

Treatment and Management

  • Treatment for moderate disease primarily consists of supportive care, including alcohol cessation and nutritional support 4.
  • Corticosteroids are recommended for severe alcoholic hepatitis, with the goal of reducing short-term mortality 6, 4.
  • Pharmacologic treatment of alcohol use disorder can aid patients in maintaining abstinence from alcohol 4.
  • Long-term follow-up should focus on abstinence from alcohol, management of underlying cirrhosis, and evaluation for liver transplantation if indicated 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Alcoholic hepatitis.

Clinics in liver disease, 2006

Research

Alcoholic hepatitis.

American family physician, 1993

Research

Alcoholic Hepatitis: Diagnosis and Management.

American family physician, 2022

Research

Prothrombin time predicts steroid response in severe alcohol-related hepatitis.

Liver international : official journal of the International Association for the Study of the Liver, 2024

Research

Prednisolone or pentoxifylline for alcoholic hepatitis.

The New England journal of medicine, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.